ASP Isotopes Inc. (ASPI)

3.4400 +0.0600 (+1.78%) At close: 04:00PM EDT

ASP Isotopes Inc.

1101 Pennsylvania Avenue NW
Suite 300
Washington, DC 20004
United States
202 756 2245
https://aspisotopes.com

Sector(s): Basic Materials
Industry: Chemicals
Full-time employees: 76

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Paul Elliot Mann	President, CEO & Executive Chairman	260k	N/A	1977
Mr. Robert Ainscow	CFO & COO	133.33k	N/A	1977
Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D.	CTO & Director	240k	N/A	1961

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

Corporate governance

ASP Isotopes Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.